135 related articles for article (PubMed ID: 38163521)
1. Carbon Ion and Photon Radiation Therapy Show Enhanced Antitumoral Therapeutic Efficacy With Neoantigen RNA-LPX Vaccines in Preclinical Colon Carcinoma Models.
Salomon N; Helm A; Selmi A; Fournier C; Diken M; Schrörs B; Scholz M; Kreiter S; Durante M; Vascotto F
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):936-945. PubMed ID: 38163521
[TBL] [Abstract][Full Text] [Related]
2. Experimental evidence that carbon-ion radiotherapy utilizes cytotoxic T lymphocyte-mediated anti-tumor immunity for shrinking tumors compared to X-ray therapy.
Takeshima T; Hirayama R; Hasegawa S
Biochem Biophys Res Commun; 2024 Jul; 718():150058. PubMed ID: 38729076
[TBL] [Abstract][Full Text] [Related]
3. A liposomal RNA vaccine inducing neoantigen-specific CD4
Salomon N; Vascotto F; Selmi A; Vormehr M; Quinkhardt J; Bukur T; Schrörs B; Löewer M; Diken M; Türeci Ö; Sahin U; Kreiter S
Oncoimmunology; 2020 Jun; 9(1):1771925. PubMed ID: 32923128
[TBL] [Abstract][Full Text] [Related]
4. The Immunogenicity and Anti-tumor Efficacy of a Rationally Designed Neoantigen Vaccine for B16F10 Mouse Melanoma.
Zhang Y; Lin Z; Wan Y; Cai H; Deng L; Li R
Front Immunol; 2019; 10():2472. PubMed ID: 31749795
[TBL] [Abstract][Full Text] [Related]
5. A Novel Engineered AAV-Based Neoantigen Vaccine in Combination with Radiotherapy Eradicates Tumors.
Huang KC; Lai CY; Hung WZ; Chang HY; Lin PC; Chiang SF; Ke TW; Liang JA; Shiau AC; Yang PC; Chen WT; Chao KSC
Cancer Immunol Res; 2023 Jan; 11(1):123-136. PubMed ID: 36315960
[TBL] [Abstract][Full Text] [Related]
6. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.
Chakraborty M; Abrams SI; Coleman CN; Camphausen K; Schlom J; Hodge JW
Cancer Res; 2004 Jun; 64(12):4328-37. PubMed ID: 15205348
[TBL] [Abstract][Full Text] [Related]
7. Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16
Salomon N; Selmi A; Grunwitz C; Kong A; Stanganello E; Neumaier J; Petschenka J; Diken M; Kreiter S; Türeci Ö; Sahin U; Vascotto F
Cancer Immunol Immunother; 2022 Aug; 71(8):1975-1988. PubMed ID: 34971406
[TBL] [Abstract][Full Text] [Related]
8. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.
Kranz LM; Diken M; Haas H; Kreiter S; Loquai C; Reuter KC; Meng M; Fritz D; Vascotto F; Hefesha H; Grunwitz C; Vormehr M; Hüsemann Y; Selmi A; Kuhn AN; Buck J; Derhovanessian E; Rae R; Attig S; Diekmann J; Jabulowsky RA; Heesch S; Hassel J; Langguth P; Grabbe S; Huber C; Türeci Ö; Sahin U
Nature; 2016 Jun; 534(7607):396-401. PubMed ID: 27281205
[TBL] [Abstract][Full Text] [Related]
9. Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens.
Bekri S; Rodney-Sandy R; Gruenstein D; Mei A; Bogen B; Castle J; Levey D; Cho HJ
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35190376
[TBL] [Abstract][Full Text] [Related]
10. Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models.
Zhang R; Yuan F; Shu Y; Tian Y; Zhou B; Yi L; Zhang X; Ding Z; Xu H; Yang L
Cancer Immunol Immunother; 2020 Jan; 69(1):135-145. PubMed ID: 31807878
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen.
Sharabi AB; Nirschl CJ; Kochel CM; Nirschl TR; Francica BJ; Velarde E; Deweese TL; Drake CG
Cancer Immunol Res; 2015 Apr; 3(4):345-55. PubMed ID: 25527358
[TBL] [Abstract][Full Text] [Related]
12. Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.
Li L; Zhang X; Wang X; Kim SW; Herndon JM; Becker-Hapak MK; Carreno BM; Myers NB; Sturmoski MA; McLellan MD; Miller CA; Johanns TM; Tan BR; Dunn GP; Fleming TP; Hansen TH; Goedegebuure SP; Gillanders WE
Genome Med; 2021 Apr; 13(1):56. PubMed ID: 33879241
[TBL] [Abstract][Full Text] [Related]
13. Differential Immune Modulation With Carbon-Ion Versus Photon Therapy.
Spina CS; Tsuruoka C; Mao W; Sunaoshi MM; Chaimowitz M; Shang Y; Welch D; Wang YF; Venturini N; Kakinuma S; Drake CG
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):813-818. PubMed ID: 33190969
[TBL] [Abstract][Full Text] [Related]
14. mRNA-based vaccines synergize with radiation therapy to eradicate established tumors.
Fotin-Mleczek M; Zanzinger K; Heidenreich R; Lorenz C; Kowalczyk A; Kallen KJ; Huber SM
Radiat Oncol; 2014 Aug; 9():180. PubMed ID: 25127546
[TBL] [Abstract][Full Text] [Related]
15. Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model.
Peterson M; Murphy SN; Lainson J; Zhang J; Shen L; Diehnelt CW; Johnston SA
BMC Immunol; 2020 May; 21(1):25. PubMed ID: 32370785
[TBL] [Abstract][Full Text] [Related]
16. Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
Martin SD; Brown SD; Wick DA; Nielsen JS; Kroeger DR; Twumasi-Boateng K; Holt RA; Nelson BH
PLoS One; 2016; 11(5):e0155189. PubMed ID: 27192170
[TBL] [Abstract][Full Text] [Related]
17. A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8
Duperret EK; Perales-Puchalt A; Stoltz R; G H H; Mandloi N; Barlow J; Chaudhuri A; Sardesai NY; Weiner DB
Cancer Immunol Res; 2019 Feb; 7(2):174-182. PubMed ID: 30679156
[TBL] [Abstract][Full Text] [Related]
18. Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer.
Kinkead HL; Hopkins A; Lutz E; Wu AA; Yarchoan M; Cruz K; Woolman S; Vithayathil T; Glickman LH; Ndubaku CO; McWhirter SM; Dubensky TW; Armstrong TD; Jaffee EM; Zaidi N
JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333318
[TBL] [Abstract][Full Text] [Related]
19. Nonlysosomal Route of mRNA Delivery and Combining with Epigenetic Regulation Optimized Antitumor Immunoprophylactic Efficacy.
Liu Y; Liu X; Huang J; Shi Y; Luo Z; Zhang J; Guo X; Jiang M; Li X; Yin H; Qin B; Guan G; Luo L; Zhou Y; You J
Adv Healthc Mater; 2023 Feb; 12(4):e2202460. PubMed ID: 36366890
[TBL] [Abstract][Full Text] [Related]
20. Neoantigen vaccine: an emerging tumor immunotherapy.
Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z
Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
